Notch-Hes1 pathway is required for the development of IL-17–producing γδ T cells

Kensuke Shibata, Hisakata Yamada, Tetsuya Sato, +10

Blood

<scp>SEMA</scp> 3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

James W. Peacock, Ario Takeuchi, Norihiro Hayashi, +22

EMBO Molecular Medicine

IL‐17 production by γδ T cells is important for the antitumor effect of <i>Mycobacterium bovis</i> bacillus Calmette‐Guérin treatment against bladder cancer

Ario Takeuchi, Takashi Dejima, Hisakata Yamada, +6

European Journal of Immunology

Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer

Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, +9

The Journal of Urology

Protective Role of Naturally Occurring Interleukin-17A-Producing γδ T Cells in the Lung at the Early Stage of Systemic Candidiasis in Mice

Takashi Dejima, Kensuke Shibata, Hisakata Yamada, +4

Infection and Immunity

Microbial PathogensLung InflammationAdaptive Immune SystemT-regulatory CellInnate Immune System +18

Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor

Masaki Shiota, Keijiro Kiyoshima, Akira Yokomizo, +7

The Journal of Urology

Surgical OncologyIntravesical RecurrenceAndrogen SuppressionRecurrent Bladder CancerOncology +15

Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB‐1, and androgen receptor

Masaki Shiota, Eiji Kashiwagi, Akira Yokomizo, +7

The Prostate

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism

Masaki Shiota, Naohiro Fujimoto, Akira Yokomizo, +7

Prostate Cancer and Prostatic Diseases

Srd5a2 PolymorphismAndrogen-deprivation TherapyAndrologyUrologyGenitourinary Cancer +7

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants

Masaki Shiota, Takashi Dejima, Yoshiaki Yamamoto, +8

Cancer Science

Molecular PharmacologyAndrogen ReceptorUrologyOncologyEnzalutamide Resistance +13

Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer

Ario Takeuchi, Masatoshi Eto, Katsunori Tatsugami, +11

International Immunopharmacology

Tumor BiologyAntitumor ActivityGenitourinary CancerMedicineRecombinant Bacille Calmette-guérin +5